result 805 件
| JaLCDOI | 10.18926/AMO/51909 |
|---|---|
| FullText URL | fulltext.pdf |
| Author | Mimura, Hidefumi| Kanazawa, Susumu| Yasui, Kotaro| Fujiwara, Hiroyasu| Hyodo, Tsuyoshi| Mukai, Takashi| Dendo, Shuichi| Iguchi, Toshihiro| Hiraki, Takao| Koshima, Isao| Hiraki, Yoshio| |
| Abstract | This retrospective study evaluated the safety and efficacy of using polidocanol with X-ray fluoroscopy for percutaneous sclerotherapy of venous malformations of the limbs, head, and neck. The subjects were 16 of 18 patients who presented to our department with venous malformations. Two patients were excluded because they were unlikely to benefit from the treatment. Of the 16 included in the study, 1 could not be treated because of inaccessibility, and another was lost to follow-up. Among the 14 cases that we were able to follow-up, 11 cases had had pain as their primary symptom. Following treatment, this symptom remained unchanged in 1 patient, was improved in 4, and had disappeared in 6; however, there was a recurrence of pain for 3 of these patients. Two patients had sought treatment for cosmetic purposes; following treatment, the lesion disappeared in one and showed a significant reduction in the other. The remaining patient presented with a primary symptom of mouth bleeding, which disappeared following treatment. There were no critical complications. Percutaneous sclerotherapy of venous malformations using polidocanol is safe and effective, and permits repeat treatments. The efficacy is especially good for resolving pain, and complications are minor. It is desirable to use fluoroscopy for these procedures |
| Keywords | venous malformation sclerotherapy polidocanol fluoroscopy guidance |
| Amo Type | Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2003-10 |
| Volume | volume57 |
| Issue | issue5 |
| Publisher | Okayama University Medical School |
| Start Page | 227 |
| End Page | 234 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 14679400 |
| Web of Science KeyUT | 000186186000003 |
| JaLCDOI | 10.18926/AMO/49669 |
|---|---|
| FullText URL | 67_2_105.pdf |
| Author | Alafate, Aierken| Shinya, Takayoshi| Okumura, Yoshihiro| Sato, Shuhei| Hiraki, Takao| Ishii, Hiroaki| Gobara, Hideo| Kato, Katsuya| Fujiwara, Toshiyoshi| Miyoshi, Shinichiro| Kaji, Mitsumasa| Kanazawa, Susumu| |
| Abstract | We retrospectively evaluated the accumulation of fluorodeoxy glucose (FDG) in pulmonary malignancies without local recurrence during 2-year follow-up on positron emission tomography (PET)/computed tomography (CT) after radiofrequency ablation (RFA). Thirty tumors in 25 patients were studied (10 non-small cell lung cancers;20 pulmonary metastatic tumors). PET/CT was performed before RFA, 3 months after RFA, and 6 months after RFA. We assessed the FDG accumulation with the maximum standardized uptake value (SUVmax) compared with the diameters of the lesions. The SUVmax had a decreasing tendency in the first 6 months and, at 6 months post-ablation, FDG accumulation was less affected by inflammatory changes than at 3 months post-RFA. The diameter of the ablated lesion exceeded that of the initial tumor at 3 months post-RFA and shrank to pre-ablation dimensions by 6 months post-RFA. SUVmax was more reliable than the size measurements by CT in the first 6 months after RFA, and PET/CT at 6 months post-RFA may be more appropriate for the assessment of FDG accumulation than that at 3 months post-RFA. |
| Keywords | fluorodeoxy glucose (FDG) positron emission tomography (PET) standardized uptake value (SUV) radiofrequency ablation (RFA) non-small cell lung cancer (NSCLC) |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2013-04 |
| Volume | volume67 |
| Issue | issue2 |
| Publisher | Okayama University Medical School |
| Start Page | 105 |
| End Page | 112 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2013 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 23603927 |
| Web of Science KeyUT | 000317801700005 |
| Related Url | http://ousar.lib.okayama-u.ac.jp/metadata/50688 |
| Author | Mitani, Masahiko| Togami, Izumi| Kitagawa, Takahiro| Katoh, Katsuya| Kanazawa, Susumu| Joja, Ikuo| Hiraki, Yoshio| Ando, Akio| Shimizu, Nobuyoshi| Teramoto, Shigeru| |
|---|---|
| Published Date | 1992-06-20 |
| Publication Title | 肺癌 |
| Volume | volume32 |
| Issue | issue3 |
| Content Type | Journal Article |
| JaLCDOI | 10.18926/AMO/47265 |
|---|---|
| FullText URL | 65_6_395.pdf |
| Author | Harada, Sosuke| Sato, Shuhei| Suzuki, Etsuji| Okumura, Yoshihiro| Hiraki, Takao| Gobara, Hideo| Mimura, Hidefumi| Kanazawa, Susumu| Kaji, Mitsumasa| Fujiwara, Toshiyoshi| |
| Abstract | The aim of the present study was to assess the diagnostic usefulness of Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in the prediction of local recurrence of malignant lung tumors by analyzing the pre-radiofrequency ablation (RFA) maximal standardized uptake value (SUVmax). We performed a historical cohort study of consecutive malignant lung tumors treated by RFA from January 2007 to May 2008 at Okayama University Hospital. We selected only lung tumors examined by PET/CT within 90 days before RFA and divided them (10 primary and 29 metastatic) into 3 groups according to their tertiles of SUVmax. We calculated recurrence odds ratios in the medium group and the high group compared to the low group using multivariate logistic analysis. After we examined the relationship between SUVmax and recurrence in a crude model, we adjusted for some factors. Tumors with higher SUVmax showed higher recurrence odds ratios (medium group;1.84, high group;4.14, respectively). The tumor size also increased the recurrence odds ratio (2.67);we thought this was mainly due to selection bias because we excluded tumors less than 10mm in diameter. This study demonstrated the pre-RFA SUVmax in PET/CT may be a prognostic factor for local recurrence of malignant lung tumors. |
| Keywords | fluorodeoxyglucose (FDG) positron emission tomography (PET) standardized uptake value (SUV) radiofrequency ablation (RFA) lung |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2011-12 |
| Volume | volume65 |
| Issue | issue6 |
| Publisher | Okayama University Medical School |
| Start Page | 395 |
| End Page | 402 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2011 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 22189480 |
| Web of Science KeyUT | 000298516900006 |
| JaLCDOI | 10.18926/AMO/47010 |
|---|---|
| FullText URL | 65_5_287.pdf |
| Author | Hiraki, Takao| Gobara, Hideo| Mimura, Hidefumi| Toyooka, Shinichi| Fujiwara, Hiroyasu| Yasui, Kotaro| Sano, Yoshifumi| Iguchi, Toshihiro| Sakurai, Jun| Tajiri, Nobuhisa| Mukai, Takashi| Matsui, Yusuke| Kanazawa, Susumu| |
| Abstract | The application of radiofrequency ablation for the treatment of lung cancer by our group at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences began in June 2001, and in the present report, we review our 10-year experience with this treatment modality at Okayama University Hospital. The local efficacy of radiofrequency ablation for the treatment of lung cancer depends on tumor size and the type of electrode used, but not on tumor type. An important factor for the prevention of local failure may be the acquisition of an adequate ablative margin. The combination of embolization and radiation therapy enhances the local efficacy. Local failure may be salvaged by repeating the radiofrequency ablation, particularly in small tumors. Survival rates after radiofrequency ablation are quite promising for patients with clinical stage I non-small cell lung cancer and pulmonary metastasis from colorectal cancer, hepatocellular carcinoma, and renal cell carcinoma. The complications caused by radiofrequency ablation can be treated conservatively in the majority of cases. However, attention should be paid to rare but serious complications. This review shows that radiofrequency ablation is a promising treatment for patients with lung cancer. |
| Keywords | radiofrequency ablation lung cancer local efficacy survival complication |
| Amo Type | Review |
| Publication Title | Acta Medica Okayama |
| Published Date | 2011-10 |
| Volume | volume65 |
| Issue | issue5 |
| Publisher | Okayama University Medical School |
| Start Page | 287 |
| End Page | 297 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2011 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 22037265 |
| Web of Science KeyUT | 000296116400002 |
| Author | 長田 高寿| 木山 敦麿| 内田 豊| 方円 幸彦| |
|---|---|
| Published Date | 1955-02-28 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume66 |
| Issue | issue10 suppl |
| Content Type | Journal Article |
| Author | Uchida, Yutaka| |
|---|---|
| Published Date | 1955-02-28 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume66 |
| Issue | issue10 suppl |
| Content Type | Journal Article |
| Author | Hoen, Yukihiko| |
|---|---|
| Published Date | 1955-02-28 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume66 |
| Issue | issue10 suppl |
| Content Type | Journal Article |
| Author | Hiraki, Kiyosi| Katuyama, Sakae| |
|---|---|
| Published Date | 1935-10-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume47 |
| Issue | issue10 |
| Content Type | Journal Article |
| Author | Hiraki, Kiyosi| |
|---|---|
| Published Date | 1941-10-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume53 |
| Issue | issue10 |
| Content Type | Journal Article |
| Author | Hiraki, Kiyosi| |
|---|---|
| Published Date | 1941-09-30 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume53 |
| Issue | issue9 |
| Content Type | Journal Article |
| Author | Hiraki, Kiyoshi| |
|---|---|
| Published Date | 1942-07-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume54 |
| Issue | issue7 |
| Content Type | Journal Article |
| Author | Hiraki, Kiyosi| |
|---|---|
| Published Date | 1942-06-30 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume54 |
| Issue | issue6 |
| Content Type | Journal Article |
| Author | Hiraki, K.| |
|---|---|
| Published Date | 1942-04-30 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume54 |
| Issue | issue4 |
| Content Type | Journal Article |
| Author | Hiraki, Kiyoshi| |
|---|---|
| Published Date | 1943-01-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume55 |
| Issue | issue1 |
| Content Type | Journal Article |
| Author | 平木 潔| 佐久間 昌章| 兒子 卓| |
|---|---|
| Published Date | 1948-07-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume60 |
| Issue | issue3 |
| Content Type | Journal Article |
| Author | 平木 潔| 石合 亨| |
|---|---|
| Published Date | 1948-05-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume60 |
| Issue | issue1-2 |
| Content Type | Journal Article |
| Author | 平木 潔| 棚橋 祐作| |
|---|---|
| Published Date | 1949-10-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume61 |
| Issue | issue8 |
| Content Type | Journal Article |
| Author | 平木 潔| 石田 收作| 志態 常也| |
|---|---|
| Published Date | 1949-10-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume61 |
| Issue | issue8 |
| Content Type | Journal Article |
| Author | 平木 潔| 棚橋 祐作| |
|---|---|
| Published Date | 1949-05-31 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume61 |
| Issue | issue4 |
| Content Type | Journal Article |
